Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
NPJ Breast Cancer
|
July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapy
Jesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial
Abdulazeez Salawu, Ben X Wang, Ming Han, et al.
Clinical Colorectal Cancer
|
July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Mitchell J Elliott, Karen Howarth, Sasha Main, et al.
JCO Precision Oncology
|
August 23, 2024
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, et al.
Cell Reports
|
October 26, 2023
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
Hyeyeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, et al.
Cell Reports
|
October 17, 2023
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
Hyeyeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, et al.
The Journal of Clinical Investigation
|
February 2, 2021
RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors
Parasvi S Patel, Karan Joshua Abraham, Kiran Kumar Naidu Guturi, et al.
Cancer Cell
|
January 27, 2015
Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression
Isaac S Harris, Aislinn E Treloar, Satoshi Inoue, et al.
Nature Communications
|
August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
S Y Cindy Yang, Scott C Lien, Ben X Wang, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
NPJ Breast Cancer
|
July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapy
Jesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial
Abdulazeez Salawu, Ben X Wang, Ming Han, et al.
Clinical Colorectal Cancer
|
July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer
Mitchell J Elliott, Karen Howarth, Sasha Main, et al.
JCO Precision Oncology
|
August 23, 2024
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, et al.
Cell Reports
|
October 26, 2023
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
Hyeyeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, et al.
Cell Reports
|
October 17, 2023
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
Hyeyeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, et al.
The Journal of Clinical Investigation
|
February 2, 2021
RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors
Parasvi S Patel, Karan Joshua Abraham, Kiran Kumar Naidu Guturi, et al.
Cancer Cell
|
January 27, 2015
Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression
Isaac S Harris, Aislinn E Treloar, Satoshi Inoue, et al.
Nature Communications
|
August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
S Y Cindy Yang, Scott C Lien, Ben X Wang, et al.
Page
of 12